High prevalence of circulating myositis-associated antibodies in non-COVID critical illness
- PMID: 38657302
- DOI: 10.1016/j.resmer.2024.101088
High prevalence of circulating myositis-associated antibodies in non-COVID critical illness
Keywords: Acute respiratory distress syndrome; Autoantibodies; COVID-19; Interstitial lung disease; Myositis.
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Robert Hallowell reports a relationship with The Myositis Association that includes: board membership. Robert Hallowell reports a relationship with Boehringer Ingelheim Pharmaceuticals Inc that includes: consulting or advisory. Robert Hallowell reports a relationship with Vicore Pharma Holding AB that includes: consulting or advisory. Robert Hallowell reports a relationship with Wolters Kluwer UpToDate that includes: consulting or advisory. Robert Hallowell reports a relationship with Teladoc Health Inc that includes: consulting or advisory. Rebecca Baron reports a relationship with Merck & Co Inc that includes: consulting or advisory. Rebecca Baron reports a relationship with Genentech that includes: consulting or advisory. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical